CSE Global Limited (SGX:544)

Market Cap	490.21M
Revenue (ttm)	861.17M
Net Income (ttm)	26.35M
Shares Out	715.64M
EPS (ttm)	0.04
PE Ratio	17.54
Forward PE	12.74
Dividend	0.02 (3.50%)
Ex-Dividend Date	Apr 25, 2025

Volume	11,141,100
Average Volume	6,645,800
Open	0.7000
Previous Close	0.6950
Day's Range	0.6750 - 0.7100
52-Week Range	0.3750 - 0.7100
Beta	0.53
RSI	68.02
Earnings Date	Aug 6, 2025

About Blueprint Medicines

CSE Global Limited, an investment holding company, engages in the provision of integrated industrial automation, information technology, and intelligent transport solutions in the Asia Pacific, the Americas, Europe, the Middle East, and Africa. The company offers process control, safety shutdown, fire and gas detection, supervisory control and data acquisition (SCADA), wellhead and subsea control, process skid, real-time information, and intelligent transport systems; two-way radio communication, fiber optic, microwave radio, conventional and t...

• Industry: Information Technology Services
• Sector: Technology
• Founded: 1985
• Employees: 1,503
• Stock Exchange: Singapore Exchange
• Ticker Symbol: 544

Financial Performance

In 2024, CSE Global's revenue was 861.17 million, an increase of 18.77% compared to the previous year's 725.05 million. Earnings were 26.35 million, an increase of 16.95%.